{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:18:39Z","timestamp":1778890719739,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00393-022-01160-1","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T09:02:26Z","timestamp":1643706146000},"page":"182-188","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tumorlokalisation und Therapie der onkogenen Osteomalazie","Tumor localization and treatment of tumor-induced osteomalacia"],"prefix":"10.1007","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7965-1946","authenticated-orcid":false,"given":"Frank Timo","family":"Beil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"St\u00fcrznickel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Rolvien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Amling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Oheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,1]]},"reference":[{"key":"1160_CR1","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1172\/JCI18563","volume":"112","author":"T Berndt","year":"2003","unstructured":"Berndt\u00a0T, Craig\u00a0TA, Bowe\u00a0AE et al (2003) Secreted frizzled-related protein 4 is a\u00a0potent tumor-derived phosphaturic agent. J\u00a0Clin Invest 112:785\u2013794","journal-title":"J Clin Invest"},{"key":"1160_CR2","first-page":"1238","volume":"12","author":"P Bordier","year":"1964","unstructured":"Bordier\u00a0P, Matrajt\u00a0H, Miravet\u00a0L et\u00a0al (1964) Histological measure of the volume and resorption of bone joints. Pathol Biol 12:1238\u20131243","journal-title":"Pathol Biol"},{"key":"1160_CR3","doi-asserted-by":"publisher","first-page":"116064","DOI":"10.1016\/j.bone.2021.116064","volume":"152","author":"ML Brandi","year":"2021","unstructured":"Brandi\u00a0ML, Clunie\u00a0GPR, Houillier\u00a0P et al (2021) Challenges in the management of tumor-induced osteomalacia (TIO). Bone 152:116064","journal-title":"Bone"},{"key":"1160_CR4","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.bone.2014.04.016","volume":"64","author":"S Breer","year":"2014","unstructured":"Breer\u00a0S, Brunkhorst\u00a0T, Beil\u00a0FT et al (2014) 68Ga DOTA-TATE PET\/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT\/CT. Bone 64:222\u2013227","journal-title":"Bone"},{"key":"1160_CR5","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1210\/jc.2004-0357","volume":"90","author":"TO Carpenter","year":"2005","unstructured":"Carpenter\u00a0TO, Ellis\u00a0BK, Insogna\u00a0KL et al (2005) Fibroblast growth factor 7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors. J\u00a0Clin Endocrinol Metab 90:1012\u20131020","journal-title":"J Clin Endocrinol Metab"},{"key":"1160_CR6","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1002\/jbmr.1881","volume":"28","author":"WH Chong","year":"2013","unstructured":"Chong\u00a0WH, Andreopoulou\u00a0P, Chen\u00a0CC et al (2013) Tumor localization and biochemical response to cure in tumor-induced osteomalacia. J\u00a0Bone Miner Res 28:1386\u20131398","journal-title":"J Bone Miner Res"},{"key":"1160_CR7","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1530\/ERC-11-0006","volume":"18","author":"WH Chong","year":"2011","unstructured":"Chong\u00a0WH, Molinolo\u00a0AA, Chen\u00a0CC et al (2011) Tumor-induced osteomalacia. Endocr Relat Cancer 18:R53\u201377","journal-title":"Endocr Relat Cancer"},{"key":"1160_CR8","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1210\/jc.2012-3642","volume":"98","author":"RJ Clifton-Bligh","year":"2013","unstructured":"Clifton-Bligh\u00a0RJ, Hofman\u00a0MS, Duncan\u00a0E et al (2013) Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET\/CT. J\u00a0Clin Endocrinol Metab 98:687\u2013694","journal-title":"J Clin Endocrinol Metab"},{"key":"1160_CR9","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s00198-020-05369-1","volume":"31","author":"L Colangelo","year":"2020","unstructured":"Colangelo\u00a0L, Pepe\u00a0J, Nieddu\u00a0L et al (2020) Long-term bone mineral density changes after surgical cure of patients with tumor-induced osteomalacia. Osteoporos Int 31:1383\u20131387","journal-title":"Osteoporos Int"},{"key":"1160_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41581-019-0189-5","volume":"16","author":"D Edmonston","year":"2020","unstructured":"Edmonston\u00a0D, Wolf\u00a0M (2020) FGF23 at the crossroads of phosphate, iron economy and erythropoiesis. Nat Rev Nephrol 16:7\u201319","journal-title":"Nat Rev Nephrol"},{"key":"1160_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","volume":"28","author":"AL Folpe","year":"2004","unstructured":"Folpe\u00a0AL, Fanburg-Smith\u00a0JC, Billings\u00a0SD et al (2004) Most osteomalacia-associated mesenchymal tumors are a\u00a0single histopathologic entity: an analysis of 32\u00a0cases and a\u00a0comprehensive review of the literature. Am J Surg Pathol 28:1\u201330","journal-title":"Am J Surg Pathol"},{"key":"1160_CR12","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1359\/jbmr.070304","volume":"22","author":"JL Geller","year":"2007","unstructured":"Geller\u00a0JL, Khosravi\u00a0A, Kelly\u00a0MH et al (2007) Cinacalcet in the management of tumor-induced osteomalacia. J\u00a0Bone Miner Res 22:931\u2013937","journal-title":"J Bone Miner Res"},{"key":"1160_CR13","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1056\/NEJMc070347","volume":"357","author":"E Hesse","year":"2007","unstructured":"Hesse\u00a0E, Rosenthal\u00a0H, Bastian\u00a0L (2007) Radiofrequency ablation of a\u00a0tumor causing oncogenic osteomalacia. N\u00a0Engl J Med 357:422\u2013424","journal-title":"N Engl J Med"},{"key":"1160_CR14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/jbmr.4233","volume":"36","author":"SM Jan de Beur","year":"2021","unstructured":"Jan de Beur\u00a0SM, Miller\u00a0PD, Weber\u00a0TJ et al (2021) Burosumab for the treatment of tumor-induced osteomalacia. J\u00a0Bone Miner Res 36:627\u2013635","journal-title":"J Bone Miner Res"},{"key":"1160_CR15","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S0140-6736(02)07846-7","volume":"359","author":"SM Jan de Beur","year":"2002","unstructured":"Jan de Beur\u00a0SM, Streeten\u00a0EA, Civelek\u00a0AC et\u00a0al (2002) Localisation of mesenchymal tumours by somatostatin receptor imaging. Lancet 359:761\u2013763","journal-title":"Lancet"},{"key":"1160_CR16","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1212\/01.wnl.0000225057.56863.33","volume":"67","author":"SS Ladha","year":"2006","unstructured":"Ladha\u00a0SS, Whitaker\u00a0MD, Bosch\u00a0EP (2006) Oncogenic osteomalacia: muscular weakness and multiple fractures. Neurology 67:364\u2013365","journal-title":"Neurology"},{"key":"1160_CR17","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41581-019-0159-y","volume":"15","author":"M Levi","year":"2019","unstructured":"Levi\u00a0M, Gratton\u00a0E, Forster\u00a0IC et\u00a0al (2019) Mechanisms of phosphate transport. Nat Rev Nephrol 15:482\u2013500","journal-title":"Nat Rev Nephrol"},{"key":"1160_CR18","first-page":"33","volume":"16","author":"RA McCance","year":"1947","unstructured":"McCance\u00a0RA (1947) Osteomalacia with Looser\u2019s nodes (Milkman\u2019s syndrome) due to a\u00a0raised resistance to vitamin D acquired about the age of 15\u00a0years. Q\u00a0J Med 16:33\u201346","journal-title":"Q J Med"},{"key":"1160_CR19","doi-asserted-by":"publisher","first-page":"17044","DOI":"10.1038\/nrdp.2017.44","volume":"3","author":"S Minisola","year":"2017","unstructured":"Minisola\u00a0S, Peacock\u00a0M, Fukumoto\u00a0S et al (2017) Tumour-induced osteomalacia. Nat Rev Dis Primers 3:17044","journal-title":"Nat Rev Dis Primers"},{"key":"1160_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00223-009-9216-z","volume":"84","author":"K Nawrot-Wawrzyniak","year":"2009","unstructured":"Nawrot-Wawrzyniak\u00a0K, Varga\u00a0F, Nader\u00a0A et al (2009) Effects of tumor-induced osteomalacia on the bone mineralization process. Calcif Tissue Int 84:313\u2013323","journal-title":"Calcif Tissue Int"},{"key":"1160_CR21","doi-asserted-by":"publisher","first-page":"K1","DOI":"10.1530\/EJE-13-0581","volume":"170","author":"S Piemonte","year":"2014","unstructured":"Piemonte\u00a0S, Romagnoli\u00a0E, Cipriani\u00a0C et al (2014) Six-year follow-up of a\u00a0characteristic osteolytic lesion in a\u00a0patient with tumor-induced osteomalacia. Eur J Endocrinol 170:K1\u20134","journal-title":"Eur J Endocrinol"},{"key":"1160_CR22","first-page":"554","volume":"14","author":"A Prader","year":"1959","unstructured":"Prader\u00a0A, Illig\u00a0R, Uehlinger\u00a0E et\u00a0al (1959) Rickets following bone tumor. Helv Paediatr Acta 14:554\u2013565","journal-title":"Helv Paediatr Acta"},{"key":"1160_CR23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00223-009-9275-1","volume":"85","author":"D Rendina","year":"2009","unstructured":"Rendina\u00a0D, De Filippo\u00a0G, Tauchmanova\u00a0L et al (2009) Bone turnover and the osteoprotegerin-RANKL pathway in tumor-induced osteomalacia: a\u00a0longitudinal study of five cases. Calcif Tissue Int 85:293\u2013300","journal-title":"Calcif Tissue Int"},{"key":"1160_CR24","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1007\/s002590100541","volume":"28","author":"JC Reubi","year":"2001","unstructured":"Reubi\u00a0JC, Waser\u00a0B, Schaer\u00a0JC et al (2001) Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. Eur J Nucl Med 28:836\u2013846","journal-title":"Eur J Nucl Med"},{"key":"1160_CR25","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.joca.2020.08.001","volume":"28","author":"C Ries","year":"2020","unstructured":"Ries\u00a0C, Boese\u00a0CK, Sturznickel\u00a0J et al (2020) Age-related changes of micro-morphological subchondral bone properties in the healthy femoral head. Osteoarthritis Cartilage 28:1437\u20131447","journal-title":"Osteoarthritis Cartilage"},{"key":"1160_CR26","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1006\/geno.2000.6235","volume":"67","author":"PS Rowe","year":"2000","unstructured":"Rowe\u00a0PS, de Zoysa\u00a0PA, Dong\u00a0R et\u00a0al (2000) MEPE, a\u00a0new gene expressed in bone marrow and tumors causing osteomalacia. Genomics 67:54\u201368","journal-title":"Genomics"},{"key":"1160_CR27","doi-asserted-by":"publisher","first-page":"6500","DOI":"10.1073\/pnas.101545198","volume":"98","author":"T Shimada","year":"2001","unstructured":"Shimada\u00a0T, Mizutani\u00a0S, Muto\u00a0T et al (2001) Cloning and characterization of FGF23 as a\u00a0causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S\u00a0A 98:6500\u20136505","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1160_CR28","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1210\/jc.2004-0406","volume":"89","author":"Y Takeuchi","year":"2004","unstructured":"Takeuchi\u00a0Y, Suzuki\u00a0H, Ogura\u00a0S et al (2004) Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia. J\u00a0Clin Endocrinol Metab 89:3979\u20133982","journal-title":"J Clin Endocrinol Metab"},{"key":"1160_CR29","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1359\/jbmr.080220","volume":"23","author":"H Wang","year":"2008","unstructured":"Wang\u00a0H, Yoshiko\u00a0Y, Yamamoto\u00a0R et\u00a0al (2008) Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro. J\u00a0Bone Miner Res 23:939\u2013948","journal-title":"J Bone Miner Res"},{"key":"1160_CR30","doi-asserted-by":"publisher","first-page":"R45","DOI":"10.1530\/EJE-12-0528","volume":"168","author":"JE Witteveen","year":"2013","unstructured":"Witteveen\u00a0JE, van Thiel\u00a0S, Romijn\u00a0JA et al (2013) Hungry bone syndrome: still a\u00a0challenge in the post-operative management of primary hyperparathyroidism: a\u00a0systematic review of the literature. Eur J Endocrinol 168:R45\u201353","journal-title":"Eur J Endocrinol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-022-01160-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-022-01160-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-022-01160-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T17:08:08Z","timestamp":1648660088000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-022-01160-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["1160"],"URL":"https:\/\/doi.org\/10.1007\/s00393-022-01160-1","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,1]]},"assertion":[{"value":"27 December 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"R.\u00a0Oheim erh\u00e4lt ein Vortragshonorar und einen Research Grant von Kyowa Kirin International. F.T.\u00a0Beil, J.\u00a0St\u00fcrznickel, T.\u00a0Rolvien und M.\u00a0Amling geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}